Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].
Nestle-Krämling C, Bölke E, Budach W, Peiper M, Niederacher D, Janni W, Eisenberger CF, Knoefel WT, Scherer A, Baldus SE, Lammering G, Gerber PA, Matuschek C. Nestle-Krämling C, et al. Strahlenther Onkol. 2011 Oct;187(10):656-64. doi: 10.1007/s00066-011-2251-5. Epub 2011 Aug 16. Strahlenther Onkol. 2011. PMID: 21858416 Review. German.
Post-Neoadjuvant Treatment Strategies in Breast Cancer.
Matuschek C, Jazmati D, Bölke E, Tamaskovics B, Corradini S, Budach W, Krug D, Mohrmann S, Ruckhäberle E, Fehm T, Nestle Krämling C, Dommach M, Haussmann J. Matuschek C, et al. Among authors: nestle kramling c. Cancers (Basel). 2022 Feb 28;14(5):1246. doi: 10.3390/cancers14051246. Cancers (Basel). 2022. PMID: 35267554 Free PMC article. Review.
Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast Irradiation.
Jazmati D, Bölke E, Halfmann K, Tamaskovics B, Ruckhäberle E, Fehm T, Hoffmann J, Krug D, Nestle Krämling C, Corradini S, Budach W, Mohrmann S, Haussmann J, Matuschek C. Jazmati D, et al. Among authors: nestle kramling c. Cancers (Basel). 2022 Jul 26;14(15):3636. doi: 10.3390/cancers14153636. Cancers (Basel). 2022. PMID: 35892894 Free PMC article.
Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer.
Haussmann J, Budach W, Nestle-Krämling C, Wollandt S, Tamaskovics B, Corradini S, Bölke E, Krug D, Fehm T, Ruckhäberle E, Audretsch W, Jazmati D, Matuschek C. Haussmann J, et al. Among authors: nestle kramling c. Cancers (Basel). 2022 Aug 20;14(16):4031. doi: 10.3390/cancers14164031. Cancers (Basel). 2022. PMID: 36011025 Free PMC article.
34 results